Comparative Pharmacology
Head-to-head clinical analysis: ACHES N PAIN versus BUTALBITAL ACETAMINOPHEN CAFFEINE AND CODEINE PHOSPHATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACHES N PAIN versus BUTALBITAL ACETAMINOPHEN CAFFEINE AND CODEINE PHOSPHATE.
ACHES-N-PAIN vs BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Non-selective inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), leading to decreased synthesis of prostaglandins.
Butalbital is a barbiturate that enhances GABA-A receptor activity, producing sedation; acetaminophen inhibits cyclooxygenase (COX) enzymes centrally, reducing pain and fever; caffeine is a nonselective adenosine receptor antagonist, causing vasoconstriction and central nervous system stimulation; codeine is an opioid agonist at mu-opioid receptors, providing analgesia and antitussive effects.
650 mg orally every 4-6 hours as needed, not to exceed 4000 mg per day.
1-2 capsules orally every 4 hours as needed for pain, not exceeding 6 capsules per day. Each capsule contains butalbital 50 mg, acetaminophen 300 mg, caffeine 40 mg, and codeine phosphate 30 mg.
None Documented
None Documented
Terminal elimination half-life is 2–4 hours in adults with normal renal function. In patients with hepatic impairment or severe renal impairment (CrCl <30 mL/min), half-life may be prolonged up to 6–8 hours, necessitating dose adjustment.
Butalbital: ~35 hours (range 30-50 h), long-acting barbiturate; Acetaminophen: ~2-3 hours; Caffeine: ~3-5 hours in adults; Codeine: ~2.5-3.5 hours; note that codeine's active metabolite morphine has half-life ~2-3 h, and renal impairment prolongs half-life of butalbital and codeine.
Renal excretion of unchanged drug and metabolites (primarily glucuronide conjugates) accounts for ~85% of elimination; fecal excretion accounts for ~15%. Biliary excretion is minor.
Butalbital: ~60-70% renal as unchanged drug and metabolites; Acetaminophen: ~90-100% renal within 24 hours (2-5% unchanged, rest as glucuronide and sulfate conjugates); Caffeine: ~1-2% renal unchanged, rest metabolized; Codeine: ~90% renal (10% unchanged, 40% as codeine-6-glucuronide, rest as morphine and norcodeine metabolites). Biliary/fecal excretion minimal for all components.
Category C
Category D/X
Analgesic
Barbiturate + Analgesic